PSEN2 and neoplasm: Jing et al. [22] designed a dual-aptamer modified tumor-targeting gene and Dox delivery system mediated by recombinant adenovirus (A10-3.2(Dox)/DUP-1-PEG-Ad5, ADDP-Ad5).